Search Results - Naoto Uemura

Advanced Medical Care Program for the Rapid Introduction of Healthcare Technologies to the National Health Insurance System in Japan by Keiko Ueda, Shoji Sanada, Naoto Uemura

Connect to this object online.

A randomized, placebo‐controlled study to evaluate safety and pharmacokinetics of ART‐001 with a novel oral pediatric formulation in healthy subjects by Akira Tanaka, Naoto Uemura, Kanako Kuniyeda, Haruhi Ando, Toshinori Higashi, Hiroshi Nagabukuro

Connect to this object online.

Association between psychomotor function and ALDH2 genotype after consuming barley shochu: A randomized crossover trial by Keiko Matsuura, Satoshi Kushio, Hiromitsu Imai, Hideo Kudo, Hirokazu Wakuda, Naoyuki Otani, Masae Kuranari, Ai Sekiguchi, Tetsuji Ohyama, Naoto Uemura

Connect to this object online.

A phase I study of high dose camostat mesylate in healthy adults provides a rationale to repurpose the TMPRSS2 inhibitor for the treatment of COVID‐19 by Junsaku Kitagawa, Hayato Arai, Hiroyuki Iida, Jiro Mukai, Kenji Furukawa, Seitaro Ohtsu, Susumu Nakade, Tomohiro Hikima, Miwa Haranaka, Naoto Uemura

Connect to this object online.

Safety, pharmacokinetics, and pharmacodynamics of ART‐648, a PDE4 inhibitor in healthy subjects: A randomized, placebo‐controlled phase I study by Akira Tanaka, Hiroshi Nagabukuro, Kanako Kuniyeda, Haruhi Ando, Toshinori Higashi, Hirokazu Wakuda, Naoyuki Otani, Hideo Kudo, Masae Kuranari, Hidetoshi Furuie, Naoto Uemura

Connect to this object online.

No Effect of Digoxin on Rosuvastatin Pharmacokinetics in Healthy Subjects: Utility of Oita Combination for Clinical Drug-Drug Interaction Study by Naoyuki Otani, Hirokazu Wakuda, Hiromitsu Imai, Masae Kuranari, Yasuyuki Ishii, Yuko Ito, Akihiro Okubo, Osamu Ogawa, Kenji Takeda, Tetsuji Ohyama, Tomoko Hasunuma, Naoto Uemura

Connect to this object online.

Performance Index for Types of Clinical Research Support Service Providers for Academic Research Organizations in Japan: A Cross‐Sectional Survey by Keiko Ueda, Naoto Uemura, Kotone Matsuyama, Yuji Nishizaki, Nanae Tanemura, Kento Asano, Yuki Otsuka, Naotake Yanagisawa, Toshiaki Otsuka, Shinji Yasuno, Rieko Ueda, Yumiko Seo, Hironori Nakagami, Shoji Sanada

Connect to this object online.

A phase I study to evaluate safety, pharmacokinetics, and pharmacodynamics of respiratory syncytial virus neutralizing monoclonal antibody MK‐1654 in healthy Japanese adults by Yuji Orito, Naoyuki Otani, Yuki Matsumoto, Katsukuni Fujimoto, Nobuyuki Oshima, Brian M. Maas, Luzelena Caro, Antonios O. Aliprantis, Kara S. Cox, Osamu Tokumaru, Masaaki Kodama, Hideo Kudo, Hiromitsu Imai, Naoto Uemura

Connect to this object online.

A phase I, randomized, placebo‐controlled study of molnupiravir in healthy Japanese to support special approval in Japan to treat COVID‐19 by Keisuke Nakamura, Katsukuni Fujimoto, Chihiro Hasegawa, Ikuo Aoki, Hiroyuki Yoshitsugu, Hiroyuki Ugai, Naoyoshi Yatsuzuka, Yoshiyuki Tanaka, Kenichi Furihata, Brian M. Maas, Prachi K. Wickremasingha, Kelly E. Duncan, Marian Iwamoto, Selwyn A. Stoch, Naoto Uemura

Connect to this object online.